Tarsus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TARS and other ETFs, options, and stocks.About TARS
Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of therapeutic candidates. Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as Demodex blepharitis.
TARS Key Statistics
Stock Snapshot
With a market cap of 2.74B, Tarsus Pharmaceuticals(TARS) trades at $64.10. The stock has a price-to-earnings ratio of -32.09.
On 2026-02-08, Tarsus Pharmaceuticals(TARS) stock traded between a low of $62.37 and a high of $64.76. Shares are currently priced at $64.10, which is +2.8% above the low and -1.0% below the high.
Tarsus Pharmaceuticals(TARS) shares are trading with a volume of 798.51K, against a daily average of 535.33K.
During the past year, Tarsus Pharmaceuticals(TARS) stock moved between $38.51 at its lowest and $85.25 at its peak.
During the past year, Tarsus Pharmaceuticals(TARS) stock moved between $38.51 at its lowest and $85.25 at its peak.
Analyst ratings
90%
of 10 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.